Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Insider Reports History

Entity
Company
Location
Wellington Alternative Investments Llc, 280 Congress Street, Boston, MA
Signature
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. By: Wellington Management Company LLP, as Investment Adviser By: /s/ Jennifer C. Boylan, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. 10%+ Owner Class A Common Stock 898K $68.3M $76.14 Aug 2, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Common Stock 2.5M $25M $10.00 Jun 21, 2021 Direct
Zenas BioPharma, Inc. 10%+ Owner Common Stock 802K $13.6M $17.00 Sep 16, 2024 Direct
Acrivon Therapeutics, Inc. 10%+ Owner Common Stock 888K $3.86M $4.35 Nov 17, 2022 Direct
Boundless Bio, Inc. 10%+ Owner Common Stock 556K Apr 2, 2024 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 194K Jul 22, 2024 Direct
Acrivon Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Nov 17, 2022 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 22, 2024 Direct
Boundless Bio, Inc. 10%+ Owner Series B Preferred Stock 0 Apr 2, 2024 Direct
Boundless Bio, Inc. 10%+ Owner Series C Preferred Stock 0 Apr 2, 2024 Direct
Nuvalent, Inc. 10%+ Owner Series B Preferred Stock 0 Aug 2, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series A-2 Preferred Stock 0 Jun 21, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 21, 2021 Direct
Zenas BioPharma, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Direct
Zenas BioPharma, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Direct
Zenas BioPharma, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Sep 16, 2024 Direct

Insider Reports Filed by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZBIO Zenas BioPharma, Inc. Sep 16, 2024 6 $0 4 Sep 18, 2024 10%+ Owner
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 22, 2024 3 $500K 4 Jul 22, 2024 10%+ Owner
ARTV Artiva Biotherapeutics, Inc. Jul 18, 2024 0 $0 3 Jul 18, 2024 10%+ Owner
BOLD Boundless Bio, Inc. Apr 2, 2024 4 $0 4 Apr 2, 2024 10%+ Owner
BOLD Boundless Bio, Inc. Mar 27, 2024 0 $0 3 Mar 27, 2024 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Nov 17, 2022 2 $0 4 Nov 21, 2022 10%+ Owner
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 10%+ Owner
NUVL Nuvalent, Inc. Aug 2, 2021 2 $0 4 Aug 3, 2021 10%+ Owner
NUVL Nuvalent, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 4 $0 4 Jun 22, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner